ATE326698T1 - Immunologisches test und satz zur diagnose von prostatadenokarzinom - Google Patents

Immunologisches test und satz zur diagnose von prostatadenokarzinom

Info

Publication number
ATE326698T1
ATE326698T1 AT01945401T AT01945401T ATE326698T1 AT E326698 T1 ATE326698 T1 AT E326698T1 AT 01945401 T AT01945401 T AT 01945401T AT 01945401 T AT01945401 T AT 01945401T AT E326698 T1 ATE326698 T1 AT E326698T1
Authority
AT
Austria
Prior art keywords
kit
immunological test
diagnosis
prostate adenocarcinoma
prostate
Prior art date
Application number
AT01945401T
Other languages
English (en)
Inventor
Jean-Philippe Charrier
Original Assignee
Biomerieux Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomerieux Sa filed Critical Biomerieux Sa
Application granted granted Critical
Publication of ATE326698T1 publication Critical patent/ATE326698T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57555—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the prostate

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AT01945401T 2000-06-13 2001-06-12 Immunologisches test und satz zur diagnose von prostatadenokarzinom ATE326698T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0007476A FR2810114B1 (fr) 2000-06-13 2000-06-13 Methode, procede, test immunologique et kit de diagnostic d'un adenocarcinome de la prostate ou d'une hypertrophie benigne de la prostate

Publications (1)

Publication Number Publication Date
ATE326698T1 true ATE326698T1 (de) 2006-06-15

Family

ID=8851186

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01945401T ATE326698T1 (de) 2000-06-13 2001-06-12 Immunologisches test und satz zur diagnose von prostatadenokarzinom

Country Status (9)

Country Link
US (1) US7517653B2 (de)
EP (1) EP1295125B1 (de)
AT (1) ATE326698T1 (de)
AU (1) AU2001267630A1 (de)
DE (1) DE60119731T2 (de)
ES (1) ES2264696T3 (de)
FR (1) FR2810114B1 (de)
PT (1) PT1295125E (de)
WO (1) WO2001096876A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69840669D1 (de) 1997-04-10 2009-04-30 Stichting Katholieke Univ Pca3, pca3-gene und verfahren zu ihrer verwendung
EP1222266B1 (de) 1999-09-29 2006-03-29 Diagnocure Inc. Pca3 mrna in gutartigen und bösartigen prostatageweben
EP1592809B1 (de) 2003-02-07 2013-04-10 Diagnocure Inc. Verfahren zum nachweis von prostatakrebs in einer probe
CN1926433A (zh) * 2004-03-03 2007-03-07 拜奥默里克斯公司 用于检测psa的可活化游离形式的方法及其用于诊断前列腺的良性病理学和前列腺的腺癌的用途
CA2491067A1 (en) 2004-12-24 2006-06-24 Stichting Katholieke Universiteit Mrna rations in urinary sediments and/or urine as a prognostic marker for prostate cancer
EP2487251A1 (de) * 2011-02-13 2012-08-15 Protagen AG Markersequenzen für die Diagnose von Prostatakarzinom und deren Verwendung
WO2014003709A1 (en) * 2012-06-25 2014-01-03 Empire Technology Development Llc Ultrasound based antigen binding detection
RU2524309C1 (ru) * 2013-04-18 2014-07-27 Государственное бюджетное учреждение здравоохранения Московской области "Московский областной научно-исследовательский клинический институт им. М.Ф. Владимирского" (ГБУЗ МО МОНИКИ им. М.Ф. Владимирского) Способ выбора тактики лечения местно-распространенного рака предстательной железы
CN108603883A (zh) * 2016-01-27 2018-09-28 富士胶片和光纯药株式会社 前列腺癌的判定方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9002480D0 (sv) * 1990-07-23 1990-07-23 Hans Lilja Assay of free and complexed prostate-specific antigen
DE4322342A1 (de) * 1993-07-05 1995-02-09 Gif Ges Fuer Immunologische Fo Verfahren für die Differentialdiagnostik des Prostata-Karzinoms
US5599677A (en) * 1993-12-29 1997-02-04 Abbott Laboratories Immunoassays for prostate specific antigen
US6649420B1 (en) * 1997-08-26 2003-11-18 Thomas L. Cantor Methods and devices for detecting no-complexed prostate specific I antigen
FI981185A7 (fi) * 1998-05-28 1999-11-29 Stenman Ulf Haakan Uusi diagnostinen menetelmä
FR2780791B1 (fr) * 1998-07-03 2000-09-01 Bio Merieux Methode de depistage ou de diagnostic d'un adenocarcinome ou d'une pathologie benigne de la prostate et procede de mise en oeuvre

Also Published As

Publication number Publication date
US7517653B2 (en) 2009-04-14
PT1295125E (pt) 2006-08-31
EP1295125A1 (de) 2003-03-26
ES2264696T3 (es) 2007-01-16
AU2001267630A1 (en) 2001-12-24
FR2810114B1 (fr) 2002-08-23
DE60119731D1 (de) 2006-06-22
EP1295125B1 (de) 2006-05-17
US20040038321A1 (en) 2004-02-26
WO2001096876A1 (fr) 2001-12-20
FR2810114A1 (fr) 2001-12-14
DE60119731T2 (de) 2007-04-26

Similar Documents

Publication Publication Date Title
EA200300605A1 (ru) Ультразвуковой зонд с позиционирующим приспособлением для позиционирования диагностических и хирургических устройств
DE69933989D1 (de) Biomarker und targets für die diagnose, prognose und behandlung von prostat krankheiten
WO1997036535A3 (en) Biomarkers for detection, diagnosis and prognosis of prostate cancer
ATE238553T1 (de) Krebsbehandlung
NO20023402D0 (no) Blandinger og fremgangsmåter for behandling og diagnose av prostatakreft
ATE254129T1 (de) Fluoreszierende chelate als gewebespezifische bildgebende mittel
NO20010196L (no) Sammensetninger og fremgangsmÕter for terapi og diagnose av prostatakreft
ATE440536T1 (de) Verfahren zur diagnose, behandlung und prävention von knochenverlust
ATE326698T1 (de) Immunologisches test und satz zur diagnose von prostatadenokarzinom
WO1999016888A3 (en) Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor
DE69717664D1 (de) Protein e25a, methoden zu dessen herstellung und anwendung
DE60032784D1 (de) Markerproteine für prostatakrebs
WO2004031414A3 (en) Method for diagnosing prostate cancer
WO2003000117A3 (en) Detection and treatment of prostate cancer
DE69900998D1 (de) Verfahren zur diagnose adenokarzinom oder benigne pathologie der vorsteherdrüse
ATE271225T1 (de) Verwendung von urintrypsininhibitor zur diagnose von aids
Shaha Advances in the management of thyroid cancer
ATE409002T1 (de) Gerät für prostatekrebsdiagnose
NO20032391L (no) Ekspresjonsanalyse av KIAA-nukleinsyrer og polypeptider anvendelige i diagnose og behandling av prostatakreft
NO20032394D0 (no) Ekspresjonsanalyse av SMARC-nukleinsyrer og polypeptider anvendelige i diagnose og behandling av prostatakreft
Mladenov et al. The diagnosis, biopsy and treatment follow-up by ultrasound in patients with prostatic carcinoma
Marczyński et al. Failure of intraoperative sentinel lymph node staining during laparoscopic ilio-obturatory lymphadenectomy in patients with prostate cancer
Riedl et al. Re: The effect of digital rectal examination, flexible cystoscopy and prostatic biopsy on free and total prostate specific antigen, and the free-to-total prostate specific antigen ratio in clinical practice
Chang Routine operative breast endoscopy during lumpectomy
UA39979C2 (uk) Спосіб ранньої діагностики онкологічних захворювань органів травлення

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties